| Product Code: ETC10576402 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Japan saw significant import shipments of dolutegravir primarily from key exporting countries including the USA, Germany, Ireland, Switzerland, and Sweden. Despite the diverse sources of imports, the market remained fairly unconcentrated with a low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) for the period 2020-2024 was -3.23%, indicating a slight decline in demand. The growth rate from 2023 to 2024 was -2.99%, reflecting a continued but moderating downward trend in the market for dolutegravir imports in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Dolutegravir Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Dolutegravir Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Dolutegravir Market - Industry Life Cycle |
3.4 Japan Dolutegravir Market - Porter's Five Forces |
3.5 Japan Dolutegravir Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Dolutegravir Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Dolutegravir Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Japan Dolutegravir Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.9 Japan Dolutegravir Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Dolutegravir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HIV/AIDS in Japan |
4.2.2 Growing adoption of dolutegravir due to its effectiveness and safety profile |
4.2.3 Government initiatives and healthcare policies supporting the use of dolutegravir |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Competition from existing HIV/AIDS treatment options |
4.3.3 Pricing pressures and reimbursement challenges |
5 Japan Dolutegravir Market Trends |
6 Japan Dolutegravir Market, By Types |
6.1 Japan Dolutegravir Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Dolutegravir Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Japan Dolutegravir Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Japan Dolutegravir Market Revenues & Volume, By Injection, 2021 - 2031F |
6.1.5 Japan Dolutegravir Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Japan Dolutegravir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Dolutegravir Market Revenues & Volume, By Antiretroviral, 2021 - 2031F |
6.2.3 Japan Dolutegravir Market Revenues & Volume, By HIV Treatment, 2021 - 2031F |
6.2.4 Japan Dolutegravir Market Revenues & Volume, By Antiviral, 2021 - 2031F |
6.3 Japan Dolutegravir Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Japan Dolutegravir Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.3.3 Japan Dolutegravir Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.4 Japan Dolutegravir Market Revenues & Volume, By Medical, 2021 - 2031F |
6.4 Japan Dolutegravir Market, By Form |
6.4.1 Overview and Analysis |
6.4.2 Japan Dolutegravir Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Japan Dolutegravir Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.4 Japan Dolutegravir Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.5 Japan Dolutegravir Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Dolutegravir Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 Japan Dolutegravir Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 Japan Dolutegravir Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 Japan Dolutegravir Market Import-Export Trade Statistics |
7.1 Japan Dolutegravir Market Export to Major Countries |
7.2 Japan Dolutegravir Market Imports from Major Countries |
8 Japan Dolutegravir Market Key Performance Indicators |
8.1 Patient adherence rates to dolutegravir treatment |
8.2 Number of healthcare facilities offering dolutegravir |
8.3 Research and development investments in dolutegravir formulation improvements |
8.4 Rate of new HIV/AIDS cases in Japan |
8.5 Adoption rate of dolutegravir compared to other antiretroviral drugs |
9 Japan Dolutegravir Market - Opportunity Assessment |
9.1 Japan Dolutegravir Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Dolutegravir Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Dolutegravir Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Japan Dolutegravir Market Opportunity Assessment, By Form, 2021 & 2031F |
9.5 Japan Dolutegravir Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Dolutegravir Market - Competitive Landscape |
10.1 Japan Dolutegravir Market Revenue Share, By Companies, 2024 |
10.2 Japan Dolutegravir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here